STSrinivas Tadepalli

Srinivas Tadepalli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Srinivas Tadepalli has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Blue carbon ecosystems under pollution stress: Impacts and integrated carbon‐pollution monitoring

    by Barun Haldar, P. Sakthivel, Srinivas Tadepalli, Anil Kumar Deepati, Sandip Kunar, T. Thirugnanasambandham, Ravikumar Jayabal, Madaminov Sanjarbek Maxmudjon Ugli

    Coastal blue carbon ecosystems, including mangroves, seagrass meadows, and salt marshes, are globally important carbon sinks because they store organic carbon in vegetation biomass and waterlogged sediments over long timescales. However, nutrient enrichment, heavy metals, petroleum hydrocarbons, macroplastic and microplastic debris, and emerging contaminants increasingly threaten their capacity to sequester carbon. These pollutants reduce photosynthetic productivity, weaken root and rhizome systems, alter sediment redox conditions, disrupt microbial decomposition pathways, and may increase emissions of carbon dioxide (CO 2 ), methane (CH 4 ), and nitrous oxide (N 2 O). This review synthesizes current evidence on how pollution alters carbon cycling across major blue carbon ecosystems, with emphasis on plant physiology, sediment stability, microbial processes, greenhouse gas (GHG) fluxes, and carbon stock permanence. It also evaluates monitoring, reporting, and verification (MRV) approaches that could integrate carbon measurements with pollutant diagnostics. In response to current methodological gaps, the review presents the Pollution‐Carbon Impact Framework (PCIF) as a conceptual decision‐support approach rather than a fully operational protocol. The PCIF is intended to guide future co‐located monitoring, indicator selection, site prioritization, and policy integration, while recognizing that standardized templates, open datasets, validated models, and Geographic Information System (GIS)‐based decision tools remain future requirements. The review concludes that reliable blue carbon accounting requires stronger integration between water‐quality governance, restoration planning, pollution control, and carbon‐credit verification.

  • Synthesis and characterization of SnO 2 ‐ SA ‐ FA nanocomposite for anticancer (cervical cancer HeLa cells), antimicrobial (methicillin‐resistant Staphylococcus aureus , Candida albicans ) and antioxidant activities

    by Binod Kr Choudhary, Patnala Ganga Raju Achary, Basavaraj Devakki, Shalini Kapoor, Indumathi Thangavelu, Srinivas Tadepalli, Ahmed A Bhran

    This study reports the synthesis and characterization of a novel sodium alginate (SA) and folic acid (FA) functionalized tin oxide nanocomposite (SnO 2 ‐SA‐FA) and investigates its antimicrobial, antioxidant and anticancer properties. XRD analysis confirmed the tetragonal crystalline structure of SnO 2 , while the crystallite size decreased from 28.3 nm for pure SnO 2 to 22.1 nm after functionalization, indicating enhanced surface area and reactivity. UV–visible analysis revealed a reduction in bandgap energy from 3.6 to 3.4 eV, suggesting improved charge transfer capability. Photoluminescence studies showed green emission at 506 nm, indicating enhanced oxygen vacancy defects and reactive oxygen species (ROS) generation. The SnO 2 ‐SA‐FA nanocomposite demonstrated enhanced antimicrobial activity against methicillin‐resistant Staphylococcus aureus and Candida albicans , exhibiting zones of inhibition of 20 mm and 17 mm, respectively, with minimum bactericidal concentration values of 1600 μg mL −1 . Antioxidant studies revealed significantly improved 2,2‐diphenyl‐1‐picrylhydrazyl radical scavenging activity, reaching 83.23% at 100 μg mL −1 compared to 66.34% for pure SnO₂ nanoparticles. Cytotoxicity studies against HeLa cervical cancer cells demonstrated dose‐dependent anticancer activity, with the SnO 2 ‐SA‐FA nanocomposite exhibiting a lower IC 50 value (concentration required to inhibit 50% of cell viability) (40.6 μg mL −1 ) than pure SnO₂ nanoparticles (58.2 μg mL −1 ). Fluorescence microscopy confirmed enhanced apoptosis induction through ROS‐mediated oxidative stress and folate‐receptor‐targeted uptake. Furthermore, biocompatibility studies on L929 fibroblast cells showed cell viability above 80%, confirming low toxicity and favorable biological safety. These findings demonstrate that the SnO 2 ‐SA‐FA nanocomposite is a promising multifunctional nanoplatform for antimicrobial, antioxidant and targeted anticancer biomedical applications. © 2026 Society of Chemical Industry.

  • Biocompatible Pluronic F127 ‐coated nickel titanate nanoparticles: toward effective antimicrobial and antioxidant therapies

    by Indumathi Thangavelu, Srinivas Tadepalli, Thalakulam Shanmugam Boopathi

    Multidrug‐resistant bacterial infections are a major global health concern. Nickel titanate (NiTiO₃) nanoparticles offer potential antimicrobial applications, but their biocompatibility is limited. This study explores the surface modification of NiTiO₃ with Pluronic F127 (PF127) to enhance biological performance. NiTiO₃ nanoparticles were synthesized and coated with PF127. Characterization was performed using XRD, FTIR, HRTEM, BET and DLS. Antibacterial activity was assessed via pathogenic bacteria assays and colony‐forming unit quantification. Antioxidant activity was measured using the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) assay, and zebrafish embryos evaluated in vivo toxicity. XRD confirmed hexagonal NiTiO₃, and FTIR/HRTEM verified PF127 incorporation. BET analysis indicated a surface area of 28.66 m 2 g −1 and mesoporous structure (2.59 nm pore diameter). DLS showed particle size reduction from 219.3 nm (NiTiO₃) to 135.9 nm (NiTiO₃–PF127), confirming improved dispersion. NiTiO₃–PF127 exhibited enhanced antibacterial activity, with colony‐forming unit counts decreasing in a concentration‐dependent manner. The DPPH assay showed 53.7% radical scavenging at 20 μg mL −1 . Zebrafish embryo studies revealed higher viability and lower developmental toxicity for PF127‐coated nanoparticles compared to uncoated NiTiO₃. PF127 modification of NiTiO₃ improves dispersion, antibacterial and antioxidant activity, and biocompatibility. These results highlight NiTiO₃–PF127 nanocomposite as a promising candidate for biomedical and antimicrobial applications. © 2026 Society of Chemical Industry.

  • Pluronic F127 –Folic Acid Modified Nickel Oxide Nanocomposites via a Facile One‐Pot Approach for In Vitro Anticancer, Antibacterial, and DPPH Radical Scavenging Studies

    by Abdelrahman G. Gadallah, Indumathi Thangavelu, Srinivas Tadepalli, Palanisamy Arulselvan

    Drug‐resistant bacteria and cancer remain major challenges in healthcare, highlighting the need for multifunctional nanomaterials. In this study, folic acid‐ and Pluronic F127‐modified nickel oxide nanocomposites (NiO–PF127–FA) were synthesized via a one‐pot method, and their in vitro antibacterial, antioxidant, and anticancer properties were evaluated. XRD analysis showed a crystallite size of 19.42 nm for NiO–PF127–FA, while PL spectra exhibited a green emission peak at 507 nm, indicative of structural defects in the NiO lattice. NiO–PF127–FA displayed enhanced antibacterial activity against MRSA and Candida albicans compared to bare NiO, as evidenced by larger inhibition zones and lower MIC and MBC values. The DPPH assay demonstrated improved radical scavenging activity of the modified nanocomposites, likely related to their smaller size, higher surface area, and surface defect‐mediated electron transfer. In vitro anticancer studies using rat C6 glioblastoma cells revealed dose‐dependent decreases in cell viability, with IC50 values of 12.3 μg/mL for NiO and 9.6 μg/mL for NiO–PF127–FA. Fluorescence staining with AO/EB and DAPI indicated morphological changes in nuclei and alterations in MMP, consistent with induction of cell death. Overall, these findings suggest that NiO–PF127–FA nanocomposites exhibit improved in vitro biological activity, providing a foundation for further preclinical investigations of their potential biomedical applications.


  • Biogenic Carboxymethyl Cellulose and L‐Histidine Coated Barium Peroxide Nanocomposite: A Tri‐Functional Platform Targeting Antimicrobial Resistance, Cancer, and Oxidative Stress

    by Srinivas Tadepalli, Mahendra Singh Rathore, Suhas Ballal, Indumathi Thangavelu, Abdelrahman G. Gadallah

    The study addresses the urgent need for novel therapeutic agents in combating multidrug‐resistant pathogens, cancer, and oxidative stress‐related diseases. Barium peroxide (BaO 2 ) nanoparticles and its novel nanocomposite, carboxymethyl cellulose and L‐histidine coated BaO 2 (BaO 2 ‐CMC‐LH) were synthesized, characterized, and evaluated for their antibacterial, anticancer, and DPPH radical scavenging activities. Structural and functional characterizations were carried out using various analytical techniques. Biological evaluations demonstrated enhanced antibacterial activity against Methicillin‐resistant Staphylococcus aureus (MRSA) and Candida albicans ( C. albicans ), with BaO 2 ‐CMC‐LH exhibiting superior inhibition zones compared to BaO 2 . For MRSA, the zone of inhibition (ZOI) for BaO 2 is about 9 mm, whereas the BaO 2 ‐CMC‐LH nanocomposite exhibits a substantially larger ZOI of 21 mm. Likewise, for C. albicans , BaO 2 presents a ZOI of 12 mm, and BaO 2 ‐CMC‐LH exhibits a greater inhibition zone of 18 mm. Cytotoxicity analysis against osteosarcoma MG‐63 cells revealed significantly improved anticancer activity, with BaO 2 ‐CMC‐LH achieving an IC₅₀ value of 28.6 μg/mL compared to 53.3 μg/mL for BaO 2 . The 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) free radical scavenging assay showed that the BaO 2 ‐CMC‐LH nanocomposite (78.45%) had activity compared to BaO 2 alone (64.43%). These findings underscore the synergistic effects of the CMC‐LH matrix in enhancing BaO 2 's biological activities, positioning BaO 2 ‐CMC‐LH as a promising multifunctional therapeutic agent for addressing global health challenges.


  • Pluronic F127 and Dopamine Functionalized Fe 2 O 3 Nanocomposites: A Multifunctional Polymer‐Based Platform for Anticancer, Antibacterial, and Antioxidant Applications

    by Nayana Borah, Subbulakshmi Ganesan, Manpreet Singh, Nidhi Srivastava, Indumathi Thangavelu, Ahmed A. Bhran, Srinivas Tadepalli

    Cancer, bacterial infections, and oxidative stress continue to pose serious global health challenges, necessitating the development of multifunctional therapeutic agents. Iron oxide (Fe 2 O 3 ) nanoparticles were selected as the core material owing to their intrinsic biocompatibility, redox activity, and established biomedical relevance. To overcome the limitations of particle aggregation and poor solubility, pluronic F127 (a biocompatible triblock copolymer) was employed as a stabilizer, while dopamine was introduced as a surface modifier to enhance functionalization, improve dispersion, and facilitate cellular uptake. The resulting Fe 2 O 3 ‐PF127‐DOP nanocomposites were thoroughly characterized using XRD, FTIR, SEM, TEM, PL, and XPS analyses, confirming successful functionalization and enhanced stability. Antioxidant assays revealed 79.24% activity at 20 μg/mL, comparable to Vitamin C, highlighting its antioxidant activity. Antibacterial studies against multiple pathogenic strains, including Pseudomonas aeruginosa , Escherichia coli , Klebsiella pneumoniae , Shigella dysenteriae , and Vibrio cholerae , showed markedly larger inhibition zones for Fe 2 O 3 ‐PF127‐DOP than for Fe 2 O 3 , confirming its broad‐spectrum antibacterial potential. Fe 2 O 3 ‐PF127‐DOP exhibited superior cytotoxicity against HCT‐116 colon cancer cells (IC 50 = 15.3 μg/mL) compared to Fe 2 O 3 (IC 50 = 17.2 μg/mL), attributed to improved uptake and ROS‐mediated apoptosis. Importantly, cytocompatibility studies on L929 fibroblast cells revealed high cell viability of 83% and 86% for Fe 2 O 3 and Fe 2 O 3 ‐PF127‐DOP, respectively, demonstrating the nanocomposite's biocompatibility. Overall, this study demonstrates that strategic functionalization of Fe 2 O 3 with pluronic F127 and dopamine yields a stable, multifunctional nanocomposite with significant anticancer, antioxidant, and antibacterial applications.

  • Biocompatible Sodium Alginate Modified BaO 2 H 2 O 2 Nanoparticles With Improved Therapeutic Efficacy Against Multidrug‐Resistant Pathogens and Cancer Cells

    by Binita Nanda, Chaitanya Lakshmi, Chandra Mouli Pandey, Ashwini Kumar, Indumathi Thangavelu, Srinivas Tadepalli, Ahmed A. Bhran

    The increasing problem of multidrug‐resistant pathogens and the limitations of conventional therapies for cancer treatments require designing new therapeutic agents. BaO 2 H 2 O 2 and BaSA nanoparticles were prepared and characterized to determine their antimicrobial, antifungal, and anticancer activities. The XRD confirmed the crystallite sizes to be 34 nm for BaO 2 H 2 O 2 and 25 nm for BaSA. The UV–visible analysis confirmed the band gap energies as 4.13 and 4.11 eV for BaO 2 H 2 O 2 and BaSA, respectively. A shift in the blue‐green PL emission from 488–510 nm in BaO 2 H 2 O 2 to 535 nm in BaSA indicated increased oxygen vacancies. EDAX analysis demonstrated elemental variations due to SA modification, whereas DLS measurements showed a decrease in the mean size of the nanoparticles from 116.70 nm (BaO 2 H 2 O 2 ) to 111.90 nm (BaSA). Antimicrobial activity was shown against Klebsiella pneumoniae , Shigella dysenteriae , Escherichia coli , Pseudomonas aeruginosa , and Proteus vulgaris , while a considerable enhancement of antifungal activity against Candida albicans was observed in BaSA. Against MG‐63 osteosarcoma cells, BaSA exhibited lower IC 50 values (21.5, 20.2, 18.7 μg mL −1 at 24, 48, and 72 h) when compared with BaO 2 H 2 O 2 (23.4, 22.5, 21.3 μg mL −1 ). Zebrafish embryos tolerated BaSA at 0.5 mg mL −1 , with developmental abnormalities observed only at 1.0 mg mL −1 .